Could Co-Diagnostics Inc (NASDAQ: CODX) Regain All Of Its Losses Given A -21.85% Dip From High?

During the recent session, Co-Diagnostics Inc (NASDAQ:CODX)’s traded shares were 1.1 million, with the beta value of the company hitting 0.62. At the last check today, the stock’s price was $0.28, reflecting an intraday loss of -3.87% or -$0.01. The 52-week high for the CODX share is $2.23, that puts it down -696.43 from that peak though still a striking 17.86% gain since the share price plummeted to a 52-week low of $0.23. The company’s market capitalization is $9.33M, and the average intraday trading volume over the past 10 days was 0.64 million shares, and the average trade volume was 305.77K shares over the past three months.

Co-Diagnostics Inc (NASDAQ:CODX) trade information

Co-Diagnostics Inc (CODX) registered a -3.87% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -3.87% in intraday trading to $0.28, hitting a weekly high. The stock’s 5-day price performance is 15.07%, and it has moved by -21.13% in 30 days. Based on these gigs, the overall price performance for the year is -73.12%. The short interest in Co-Diagnostics Inc (NASDAQ:CODX) is 0.17 million shares and it means that shorts have 0.57 day(s) to cover.

The consensus price target of analysts on Wall Street is $6, which implies an increase of 95.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, CODX is trading at a discount of -2042.86% off the target high and -2042.86% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.40%. While earnings are projected to return 13.71% in 2025, the next five years will return 37.69% per annum.

CODX Dividends

Co-Diagnostics Inc is due to release its next quarterly earnings on 2025-May-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Co-Diagnostics Inc (NASDAQ:CODX)’s Major holders

Co-Diagnostics Inc insiders own 9.00% of total outstanding shares while institutional holders control 17.44%, with the float percentage being 19.17%. VANGUARD GROUP INC is the largest shareholder of the company, while 46.0 institutions own stock in it. As of 2024-06-30, the company held over 1.78 million shares (or 5.913% of all shares), a total value of $2.23 million in shares.

The next largest institutional holding, with 0.59 million shares, is of RENAISSANCE TECHNOLOGIES LLC’s that is approximately 1.9486% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.73 million.

Also, the Mutual Funds coming in first place with the largest holdings of Co-Diagnostics Inc (CODX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.28 shares. This amounts to just over 3.80 percent of the company’s overall shares, with a $0.36 million market value. The same data shows that the other fund manager holds slightly less at 444.78, or about 1.32% of the stock, which is worth about $0.12 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.